Acne vulgaris is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
This report contains market size and forecasts of Acne Vulgaris Drug in Global, including the following market information:
Global Acne Vulgaris Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acne Vulgaris Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
OTC Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acne Vulgaris Drug include Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma and Lion, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acne Vulgaris Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acne Vulgaris Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acne Vulgaris Drug Market Segment Percentages, by Type, 2021 (%)
OTC
Prescription Medicine
Global Acne Vulgaris Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acne Vulgaris Drug Market Segment Percentages, by Application, 2021 (%)
Topical
Oral
Global Acne Vulgaris Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acne Vulgaris Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acne Vulgaris Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acne Vulgaris Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma